We are very proud that our paper on using ML and ctDNA tumor burden quantitation to predict survival in metastatic breast cancer has been highlighted by @helloeacr.bsky.social!
Work led by @emmajb001.bsky.social in close collaboration with @ruedalab.bsky.social!
magazine.eacr.org/highlights-i...